Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2004 3
2005 2
2006 1
2007 1
2008 2
2009 3
2010 10
2011 9
2012 6
2015 3
2016 8
2017 10
2018 6
2019 6
2020 9
2021 11
2022 14
2023 10
2024 11
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry.
Seheult JN, Otteson GE, Weybright MJ, Timm MM, Han W, Jevremovic D, Horna P, Olteanu H, Shi M. Seheult JN, et al. Among authors: olteanu h. Cancers (Basel). 2025 May 17;17(10):1688. doi: 10.3390/cancers17101688. Cancers (Basel). 2025. PMID: 40427185 Free PMC article.
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia.
Bohra A, Hassan R, Zanwar S, Jevremovic D, Olteanu H, Gonsalves WI, Otteson G, Horna P, Rajkumar SV, Kumar S. Bohra A, et al. Among authors: olteanu h. Leukemia. 2025 May 26. doi: 10.1038/s41375-025-02653-z. Online ahead of print. Leukemia. 2025. PMID: 40419655 No abstract available.
Acute Megakaryoblastic Leukemia Masquerading as a Germ Cell Tumor.
Olson LM, Gurney M, Li M, Yao Y, Johnson T, Olteanu H, Gangat N. Olson LM, et al. Among authors: olteanu h. Am J Hematol. 2025 Apr 28. doi: 10.1002/ajh.27698. Online ahead of print. Am J Hematol. 2025. PMID: 40293222 No abstract available.
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma.
Zanwar S, Jevremovic D, Kapoor P, Olteanu H, Buadi F, Horna P, Gonsalves W, Otteson G, Bolarinwa AB, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Gertz MA, Kourelis T, Leung N, Lin Y, Muchtar E, Warsame R, Fonder A, Hobbs M, Hwa YL, Rogers M, Kyle RA, Rajkumar SV, Kumar S. Zanwar S, et al. Among authors: olteanu h. Blood Cancer J. 2025 Feb 18;15(1):20. doi: 10.1038/s41408-025-01232-w. Blood Cancer J. 2025. PMID: 39966346 Free PMC article.
Vasculitis associated with VEXAS syndrome.
Sullivan MM, Mead-Harvey C, Sartori-Valinotti JC, Kalantari K, Kusne YN, Patnaik MM, Mangaonkar AA, Go RS, Montes D, Reichard KK, Olteanu H, Bois MC, Hines AS, Warrington KJ, Koster MJ. Sullivan MM, et al. Among authors: olteanu h. Rheumatology (Oxford). 2025 Jun 1;64(6):3889-3894. doi: 10.1093/rheumatology/keae550. Rheumatology (Oxford). 2025. PMID: 39392442 Free PMC article.
FDA IDE validation of multiple myeloma MRD test by flow cytometry.
Jevremovic D, Shi M, Horna P, Otteson GE, Timm MM, Bennett SA, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Kourelis T, Muchtar E, Zhou J, Rajkumar SV, Kumar SK, Olteanu H. Jevremovic D, et al. Among authors: olteanu h. Am J Hematol. 2024 Dec;99(12):2399-2401. doi: 10.1002/ajh.27484. Epub 2024 Sep 18. Am J Hematol. 2024. PMID: 39291868 No abstract available.
Acute kidney injury, an underrecognized feature of VEXAS syndrome.
Kalantari K, Sullivan MM, Herrera Hernandez LP, Bu L, Cornell LD, Nasr SH, Fervenza FC, Montes D, Mangaonkar AA, Go RS, Kusne YN, Patnaik MM, Lasho TL, Olteanu H, Reichard KK, Warrington KJ, Koster MJ. Kalantari K, et al. Among authors: olteanu h. Rheumatology (Oxford). 2025 Apr 1;64(4):2027-2033. doi: 10.1093/rheumatology/keae465. Rheumatology (Oxford). 2025. PMID: 39186250
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines.
Monaghan SA, Eck S, Bunting S, Dong XX, Durso RJ, Gonneau C, Hays A, Illingworth A, League SC, Linskens E, McCausland M, McCloskey TW, Rolf N, Shi M, Wallace PK, Litwin V, Kern W, Deeb G, Nash V, Olteanu H. Monaghan SA, et al. Among authors: olteanu h. Cytometry B Clin Cytom. 2025 May;108(3):252-266. doi: 10.1002/cyto.b.22202. Epub 2024 Aug 21. Cytometry B Clin Cytom. 2025. PMID: 39165120 Review.
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
Jevremovic D, Shi M, Horna P, Otteson GE, Timm MM, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Zhou J, Dispenzieri A, Kourelis T, Muchtar E, Rajkumar SV, Kumar SK, Olteanu H. Jevremovic D, et al. Among authors: olteanu h. Blood Cancer J. 2024 Jul 31;14(1):126. doi: 10.1038/s41408-024-01113-8. Blood Cancer J. 2024. PMID: 39085227 Free PMC article. No abstract available.
Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
Olteanu H, Patnaik M, Koster MJ, Herrick JL, Chen D, He R, Viswanatha D, Warrington KJ, Go RS, Mangaonkar AA, Kourelis T, Hines A, Gibson SE, Peterson JF, Reichard KK. Olteanu H, et al. Am J Clin Pathol. 2024 Jun 3;161(6):609-624. doi: 10.1093/ajcp/aqad186. Am J Clin Pathol. 2024. PMID: 38413044
Venous and arterial thrombosis in patients with VEXAS syndrome.
Kusne Y, Ghorbanzadeh A, Dulau-Florea A, Shalhoub R, Alcedo PE, Nghiem K, Ferrada MA, Hines A, Quinn KA, Panicker SR, Ombrello AK, Reichard K, Darden I, Goodspeed W, Durrani J, Wilson L, Olteanu H, Lasho T, Kastner DL, Warrington KJ, Mangaonkar A, Go RS, Braylan RC, Beck DB, Patnaik MM, Young NS, Calvo KR, Casanegra AI, Grayson PC, Koster MJ, Wu CO, Kanthi Y, Patel BA, Houghton DE, Groarke EM. Kusne Y, et al. Among authors: olteanu h. Blood. 2024 May 23;143(21):2190-2200. doi: 10.1182/blood.2023022329. Blood. 2024. PMID: 38306657 Free PMC article.
PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee.
Dorfman DM, Devitt KA, Cui W, Bashleben C, Naharro ECF, Hedley B, Hupp M, Karlon WJ, Murphy CE, Cherian S, Olteanu H, Seifert RP, Rosado FN, Linden MA. Dorfman DM, et al. Among authors: olteanu h. Arch Pathol Lab Med. 2024 Jun 1;148(6):699-704. doi: 10.5858/arpa.2023-0035-CP. Arch Pathol Lab Med. 2024. PMID: 37776247 Free article.
Superior detection rate of plasma cell FISH using FACS-FISH.
Gagnon MF, Midthun SM, Fangel JA, Schuh CM, Luoma IM, Pearce KE, Meyer RG, Ailawadhi S, Arribas MJ, Braggio E, Fonseca R, Rajkumar SV, Zepeda-Mendoza C, Xu X, Greipp PT, Timm MM, Otteson GE, Shi M, Jevremovic D, Olteanu H, Peterson JF, Ketterling RP, Kumar S, Baughn LB. Gagnon MF, et al. Among authors: olteanu h. Am J Clin Pathol. 2024 Jan 4;161(1):60-70. doi: 10.1093/ajcp/aqad108. Am J Clin Pathol. 2024. PMID: 37658775
Spectrum of clonal hematopoiesis in VEXAS syndrome.
Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho T, Shalhoub R, Ma X, Alessi H, Finke C, Koster MJ, Mangaonkar A, Warrington KJ, Begna K, Xie Z, Ombrello AK, Viswanatha D, Ferrada M, Wilson L, Go R, Kourelis T, Reichard K, Olteanu H, Darden I, Hironaka D, Alemu L, Kajigaya S, Rosenzweig S, Calado RT, Groarke EM, Kastner DL, Calvo KR, Wu CO, Grayson PC, Young NS, Beck DB, Patel BA, Patnaik MM. Gutierrez-Rodrigues F, et al. Among authors: olteanu h. Blood. 2023 Jul 20;142(3):244-259. doi: 10.1182/blood.2022018774. Blood. 2023. PMID: 37084382 Free PMC article.
Utility of flow cytometry screening before MRD testing in multiple myeloma.
Panakkal V, Lakshman A, Shi M, Olteanu H, Horna P, Timm MM, Otteson GE, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Rajkumar SV, Kumar SK, Jevremovic D. Panakkal V, et al. Among authors: olteanu h. Blood Cancer J. 2023 Apr 20;13(1):55. doi: 10.1038/s41408-023-00832-8. Blood Cancer J. 2023. PMID: 37080968 Free PMC article. No abstract available.
Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis.
Lasho T, Finke C, Timm M, Tefferi A, Mangaonkar A, Olteanu H, Reichard K, Ketterling R, Gangat N, Xie Z, Fernandez J, Chia N, Gaspar-Maia A, Binder M, Patnaik MM. Lasho T, et al. Among authors: olteanu h. Leukemia. 2023 Jun;37(6):1384-1387. doi: 10.1038/s41375-023-01887-z. Epub 2023 Mar 25. Leukemia. 2023. PMID: 36966263 No abstract available.
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Abdallah M, McCullough K, Ilyas R, Begna KH, Al-Kali A, Litzow MR, Hogan WJ, Mangaonkar A, Alkhateeb H, Shah MV, Elliott MA, Foran JM, Badar T, Palmer JM, Yi CA, Sproat L, Pardanani A, Patnaik MM, Olteanu H, Ketterling RP, Tefferi A, Gangat N. Abdallah M, et al. Among authors: olteanu h. Blood Cancer J. 2023 Mar 13;13(1):35. doi: 10.1038/s41408-023-00812-y. Blood Cancer J. 2023. PMID: 36907917 Free PMC article. No abstract available.
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
Mangaonkar AA, Langer KJ, Lasho TL, Finke C, Litzow MR, Hogan WJ, Shah MV, Go RS, Bartoo G, Kutzke J, McCullough KB, Koster M, Samec M, Warrington KJ, Reichard KK, Olteanu H, Riwes M, Patnaik MM, Alkhateeb HB. Mangaonkar AA, et al. Among authors: olteanu h. Am J Hematol. 2023 Feb;98(2):E28-E31. doi: 10.1002/ajh.26786. Epub 2022 Dec 1. Am J Hematol. 2023. PMID: 36403135 Free article. No abstract available.
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.
Jevremovic D, Nanaa A, Geyer SM, Timm M, Azouz H, Hengel C, Reberg A, He R, Viswanatha D, Salama ME, Shi M, Olteanu H, Horna P, Otteson G, Greipp PT, Xie Z, Alkhateeb HB, Hogan W, Litzow M, Patnaik MM, Shah M, Al-Kali A, Nguyen PL. Jevremovic D, et al. Among authors: olteanu h. Am J Clin Pathol. 2022 Oct 6;158(4):530-536. doi: 10.1093/ajcp/aqac083. Am J Clin Pathol. 2022. PMID: 35938646 Free PMC article.
Spurious CD34 expression in B-cell lymphoma due to nonspecific binding to PerCP-Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall.
Shi M, Timm MM, Howard MT, Jevremovic D, Yuan J, Greipp PT, Peterson JF, Roh DJ, Horna P, Olteanu H. Shi M, et al. Among authors: olteanu h. Cytometry B Clin Cytom. 2022 Jul;102(4):326-328. doi: 10.1002/cyto.b.22079. Epub 2022 Jun 2. Cytometry B Clin Cytom. 2022. PMID: 35652321 Free article. No abstract available.
Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature.
Gagnon MF, Smadbeck JB, Vasmatzis G, Olteanu H, Wood AJ, Lewis DJ, Sharma N, Meyer RG, Greipp PT, Xu X, Hoppman NL, Baughn LB, Ketterling RP, Chiu A, Peterson JF. Gagnon MF, et al. Among authors: olteanu h. Ann Diagn Pathol. 2022 Jun;58:151942. doi: 10.1016/j.anndiagpath.2022.151942. Epub 2022 Mar 23. Ann Diagn Pathol. 2022. PMID: 35344861 Review.
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.
He R, Chiou J, Chiou A, Chen D, Chen CP, Spethman C, Bessonen KR, Oliveira JL, Nguyen PL, Reichard KK, Hoyer JD, Althoff SD, Roh DJ, Miller MA, Yuan J, Olteanu H, Begna K, Tefferi A, Alkhateeb H, Patnaik MM, Litzow MR, Al-Kali A, Viswanatha DS. He R, et al. Among authors: olteanu h. Blood Cancer J. 2022 Jan 25;12(1):12. doi: 10.1038/s41408-022-00612-w. Blood Cancer J. 2022. PMID: 35078969 Free PMC article. No abstract available.
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.
Soh KT, Came N, Otteson GE, Jevremovic D, Shi M, Olteanu H, Natoni A, Lagoo A, Theakston E, Óskarsson JÞ, Gorniak M, Grigoriadis G, Arroz M, Fletcher M, Lin P, Ludwig P, Tembhare P, Matuzeviciene R, Radzevicius M, Kay S, Chen W, Cabrita C, Wallace PK. Soh KT, et al. Among authors: olteanu h. Cytometry B Clin Cytom. 2022 Mar;102(2):88-106. doi: 10.1002/cyto.b.22053. Epub 2022 Jan 10. Cytometry B Clin Cytom. 2022. PMID: 35005838 Free PMC article.
Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
Koleilat A, McGarrah PW, Olteanu H, Van Dyke DL, Smadbeck JB, Johnson SH, Vasmatzis G, Hoppman NL, Xu X, Ketterling RP, Greipp PT, Baughn LB, Patnaik MS, Peterson JF. Koleilat A, et al. Among authors: olteanu h. Cancer Genet. 2022 Jan;260-261:1-5. doi: 10.1016/j.cancergen.2021.11.002. Epub 2021 Nov 6. Cancer Genet. 2022. PMID: 34781094
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
Martin ES, Ferrer A, Mangaonkar AA, Khan SP, Kohorst MA, Joshi AY, Hogan WJ, Olteanu H, Moyer AM, Al-Kali A, Tefferi A, Chen D, Wudhikarn K, Go R, Viswanatha D, He R, Ketterling R, Nguyen PL, Oliveira JL, Gangat N, Lasho T, Patnaik MM. Martin ES, et al. Among authors: olteanu h. Am J Hematol. 2021 Nov 1;96(11):1450-1460. doi: 10.1002/ajh.26321. Epub 2021 Aug 27. Am J Hematol. 2021. PMID: 34390506 Free article.
Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma.
Guenzel AJ, Smadbeck JB, Golden CL, Williamson CM, Benevides Demasi JC, Vasmatzis G, Pearce KE, Olteanu H, Xu X, Hoppman NL, Greipp PT, Baughn LB, Ketterling RP, Peterson JF. Guenzel AJ, et al. Among authors: olteanu h. Ann Diagn Pathol. 2021 Aug;53:151761. doi: 10.1016/j.anndiagpath.2021.151761. Epub 2021 May 10. Ann Diagn Pathol. 2021. PMID: 33991782
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.
Li M, Binder M, Lasho T, Ferrer A, Gangat N, Al-Kali A, Mangaonkar A, Elliott M, Litzow M, Hogan W, Pardanani A, Wolanskyj-Spinner A, Howard M, King RL, Shah M, Alkhateeb H, Begna K, Tefferi A, Finke C, Oliveira J, Ketterling R, Olteanu H, Patnaik MM. Li M, et al. Among authors: olteanu h. Blood Adv. 2021 Apr 27;5(8):2272-2278. doi: 10.1182/bloodadvances.2020003976. Blood Adv. 2021. PMID: 33904893 Free PMC article. No abstract available.
117 results